Alexander Constantinides

Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid

G. Meijer, C. Punt, M. Lahaye, 2021, The journal of pathology. Clinical research.

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)

M. Lahaye, J. Burger, I. de Hingh, 2019, BMJ Open.

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study

I. B. Borel Rinkes, M. Koopman, T. Schwartz, 2022, Frontiers in Oncology.

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity

J. Koster, J. Laoukili, A. Huitema, 2022, British Journal of Cancer.

Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial

J. Burger, R. Mathijssen, I. de Hingh, 2019, BMJ Open.

First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II)

J. Burger, I. de Hingh, M. Los, 2021, BMJ Open.

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy

I. B. Borel Rinkes, G. Kops, O. Kranenburg, 2019, The British journal of surgery.

First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II).

M. Los, S. Elias, G. Creemers, 2024, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases

J. Medema, P. Snaebjornsson, S. V. van Hooff, 2024, Cell reports. Medicine.